Literature DB >> 29290407

Expanding Access to Clinical Services for Toddlers with Autism Spectrum Disorders.

Therese L Mathews, Ashley M Lugo, Melissa L King, Laura L Needelman, Paige E McArdle, Natalie Romer, Megan Terry, Kathryn Menousek, Joseph H Evans, William J Higgins.   

Abstract

Autism spectrum disorder (ASD) is a neurodevelopmental disorder typically diagnosed in the toddler and preschool years. Intensive early intervention (EI) using applied behavior analytic procedures is the evidenced-based intervention most effective in improving developmental outcomes. Unfortunately, there are numerous barriers to accessing EI services for toddlers with ASD. This article addresses (a) the process of developing an EI program using primarily applied behavior analytic services with multidisciplinary health care providers, (b) a description of the service delivery provided, (c) educational and training programs to increase qualified staff, and (d) advocacy efforts to improve community capacity. The EI program has sustained growth, improved child developmental outcomes, served as a training ground for EI providers, and yielded high parent satisfaction ratings. Suggestions for continued advocacy, education, research, and policy development related to the lack of access to EI for children with ASD is offered for pediatric health care providers.
Copyright © 2017 National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Access to care; autism spectrum disorder; toddlers

Mesh:

Year:  2017        PMID: 29290407     DOI: 10.1016/j.pedhc.2017.09.011

Source DB:  PubMed          Journal:  J Pediatr Health Care        ISSN: 0891-5245            Impact factor:   1.812


  1 in total

1.  Caring for children with mental health or developmental and behavioural disorders: Perspectives of family health teams on roles and barriers to care.

Authors:  Elizabeth Young; Laurie Green; Rachel Goldfarb; Kathleen Hollamby; Karen Milligan
Journal:  Can Fam Physician       Date:  2020-10       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.